ArticleCureus2026
Clinical Profile and Outcome of Resistant Gram-Negative Infections in a Pediatric Intensive Care Unit: A Retrospective Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim Healthcare-associated infections (HCAIs) cause increased morbidity and mortality in intensive care units. The aim of this study is to evaluate the characteristics of resistant, gram-negative infections in a pediatric intensive care unit (PICU) and identify clinical and microbiological risk factors associated with mortality. Comprehending these factors is essential for enhancing patient outcomes and directing treatment interventions in the PICU. Materials and methods Data were collected from pediatric patients admitted to the PICU at Queen Rania Al Abdullah Hospital for Children, Amman, Jordan, between January 2020 and December 2024. Patients with gram-negative multidrug-resistant organism (MDRO) infections receiving antimicrobial treatment were included. Demographic data, antimicrobial drug exposures, and outcomes such as mortality were recorded. Results A mortality rate of 32.3% was observed for the study sample. Gram-negative organisms such as
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.